These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33418314)

  • 1. Identification of aplysinopsin as a blood-brain barrier permeable scaffold for anti-cholinesterase and anti-BACE-1 activity.
    Nuthakki VK; Yadav Bheemanaboina RR; Bharate SB
    Bioorg Chem; 2021 Feb; 107():104568. PubMed ID: 33418314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure-activity relationship with a strong BBB permeability.
    Jannat S; Balupuri A; Ali MY; Hong SS; Choi CW; Choi YH; Ku JM; Kim WJ; Leem JY; Kim JE; Shrestha AC; Ham HN; Lee KH; Kim DM; Kang NS; Park GH
    Exp Mol Med; 2019 Feb; 51(2):1-18. PubMed ID: 30755593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
    Ali MY; Jannat S; Edraki N; Das S; Chang WK; Kim HC; Park SK; Chang MS
    Chem Biol Interact; 2019 Aug; 309():108707. PubMed ID: 31194956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.
    Gabr MT; Abdel-Raziq MS
    Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
    Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
    J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of embelin, a 3-undecyl-1,4-benzoquinone from Embelia ribes as a multitargeted anti-Alzheimer agent.
    Nuthakki VK; Sharma A; Kumar A; Bharate SB
    Drug Dev Res; 2019 Aug; 80(5):655-665. PubMed ID: 31050027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and molecular docking study of fish roe-derived peptides as potent BACE 1, AChE, and BChE inhibitors.
    Yu Z; Ji H; Shen J; Kan R; Zhao W; Li J; Ding L; Liu J
    Food Funct; 2020 Jul; 11(7):6643-6651. PubMed ID: 32656560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy.
    Waiker DK; Verma A; Gajendra TA; Namrata ; Roy A; Kumar P; Trigun SK; Srikrishna S; Krishnamurthy S; Davisson VJ; Shrivastava SK
    Eur J Med Chem; 2024 May; 271():116409. PubMed ID: 38663285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties.
    Fernández-Bachiller MI; Pérez C; Monjas L; Rademann J; Rodríguez-Franco MI
    J Med Chem; 2012 Feb; 55(3):1303-17. PubMed ID: 22243648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multitargeted C9-substituted ester and ether derivatives of berberrubine for Alzheimer's disease: Design, synthesis, biological evaluation, metabolic stability, and pharmacokinetics.
    Raghuvanshi R; Jamwal A; Nandi U; Bharate SB
    Drug Dev Res; 2023 Feb; 84(1):121-140. PubMed ID: 36461610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents.
    Galdeano C; Viayna E; Arroyo P; Bidon-Chanal A; Blas JR; Muñoz-Torrero D; Luque FJ
    Curr Pharm Des; 2010; 16(25):2818-36. PubMed ID: 20698824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation and molecular modeling studies of methyl indole-isoxazole carbohydrazide derivatives as multi-target anti-Alzheimer's agents.
    Iraji A; Nikfar P; Nazari Montazer M; Karimi M; Edraki N; Saeedi M; Mirfazli SS
    Sci Rep; 2024 Sep; 14(1):21115. PubMed ID: 39256495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease.
    Tripathi A; Choubey PK; Sharma P; Seth A; Saraf P; Shrivastava SK
    Bioorg Chem; 2020 Jan; 95():103506. PubMed ID: 31887472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice.
    Viayna E; Coquelle N; Cieslikiewicz-Bouet M; Cisternas P; Oliva CA; Sánchez-López E; Ettcheto M; Bartolini M; De Simone A; Ricchini M; Rendina M; Pons M; Firuzi O; Pérez B; Saso L; Andrisano V; Nachon F; Brazzolotto X; García ML; Camins A; Silman I; Jean L; Inestrosa NC; Colletier JP; Renard PY; Muñoz-Torrero D
    J Med Chem; 2021 Jan; 64(1):812-839. PubMed ID: 33356266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1.
    Ali MY; Seong SH; Jung HA; Jannat S; Choi JS
    Arch Pharm Res; 2018 Jul; 41(7):753-764. PubMed ID: 30047040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
    Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
    J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
    Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
    Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease.
    Tripathi A; Choubey PK; Sharma P; Seth A; Tripathi PN; Tripathi MK; Prajapati SK; Krishnamurthy S; Shrivastava SK
    Eur J Med Chem; 2019 Dec; 183():111707. PubMed ID: 31561043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease.
    Liu D; Zhang H; Wang Y; Liu W; Yin G; Wang D; Li J; Shi T; Wang Z
    Eur J Med Chem; 2022 Feb; 229():114044. PubMed ID: 34923430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo.
    Więckowska A; Więckowski K; Bajda M; Brus B; Sałat K; Czerwińska P; Gobec S; Filipek B; Malawska B
    Bioorg Med Chem; 2015 May; 23(10):2445-57. PubMed ID: 25868744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.